|
LOC728640 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.173200E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.785200E-01 |
| Normal-vs-Stage2 |
6.200000E-01 |
| Normal-vs-Stage3 |
6.332800E-01 |
| Normal-vs-Stage4 |
5.055800E-01 |
| Stage1-vs-Stage2 |
4.674400E-01 |
| Stage1-vs-Stage3 |
9.297600E-01 |
| Stage1-vs-Stage4 |
3.897800E-01 |
| Stage2-vs-Stage3 |
4.599000E-01 |
| Stage2-vs-Stage4 |
9.812000E-01 |
| Stage3-vs-Stage4 |
2.738600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.182600E-01 |
| Normal-vs-AfricanAmerican |
5.697200E-01 |
| Normal-vs-Asian |
9.302800E-01 |
| Caucasian-vs-AfricanAmerican |
1.443620E-01 |
| Caucasian-vs-Asian |
7.716600E-01 |
| AfricanAmerican-vs-Asian |
7.724400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.597200E-01 |
| Normal-vs-Female |
6.052600E-01 |
| Male-vs-Female |
6.250000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.997200E-01 |
| Normal-vs-Extreme_Weight |
3.295000E-01 |
| Normal-vs-Obese |
7.831000E-01 |
| Normal-vs-Extreme_Obese |
4.467800E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.320200E-01 |
| Normal_Weight-vs-Obese |
2.980200E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.573600E-01 |
| Extreme_Weight-vs-Obese |
1.339420E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.988000E-01 |
| Obese-vs-Extreme_Obese |
2.261400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.228800E-01 |
| Normal-vs-Age(41-60Yrs) |
6.255600E-01 |
| Normal-vs-Age(61-80Yrs) |
1.909050E-01 |
| Normal-vs-Age(81-100Yrs) |
8.806400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.235000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.131700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.304400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.462300E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.929400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.294600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.413800E-01 |
| Normal-VS-Type2 PRCC |
3.715400E-03 |
| Normal-VS-KIRP CIMP |
8.174100E-02 |
| Normal-VS-Unclassified PRCC |
6.777400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.59905000000071E-05 |
| Type1 PRCC-VS-KIRP CIMP |
2.017200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.286000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.90820000000236E-05 |
| Type2 PRCC-VS-Unclassified PRCC |
4.641900E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
6.349500E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.021200E-03 |
| Normal-vs-N1 |
4.461000E-01 |
| Normal-vs-N2 |
3.520200E-01 |
| N0-vs-N1 |
1.064880E-03 |
| N0-vs-N2 |
8.499000E-01 |
| N1-vs-N2 |
1.571550E-01 |
|
|
